SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001179110-20-001200
Filing Date
2020-02-05
Accepted
2020-02-05 18:58:54
Documents
1
Period of Report
2020-02-03

Document Format Files

Seq Description Document Type Size
1 FORM 4 - edgar.html 4  
1 FORM 4 - edgar.xml 4 4947
  Complete submission text file 0001179110-20-001200.txt   6358
Mailing Address UGLAND HOUSE, SOUTH CHURCH STREET GEORGE TOWN, GRAND CAYMAN E9 KY1-1104
Business Address UGLAND HOUSE, SOUTH CHURCH STREET GEORGE TOWN, GRAND CAYMAN E9 KY1-1104 650-808-6000
Theravance Biopharma, Inc. (Issuer) CIK: 0001583107 (see all company filings)

IRS No.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences

Mailing Address C/O ACORDA THERAPEUTICS, INC. 420 SAW MILL RIVER ROAD ARDSLEY NY 10502
Business Address
Hindman Andrew A. (Reporting) CIK: 0001607965 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36033 | Film No.: 20580390